Patents by Inventor Ryan Mooney

Ryan Mooney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20220380771
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.
    Type: Application
    Filed: March 31, 2022
    Publication date: December 1, 2022
    Inventors: Kevin Fitzgerald, Gregory Hinkle, Timothy Ryan Mooney
  • Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof
    Patent number: 11319539
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: May 3, 2022
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Kevin Fitzgerald, Gregory Hinkle, Timothy Ryan Mooney
  • XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20200299698
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.
    Type: Application
    Filed: January 27, 2020
    Publication date: September 24, 2020
    Inventors: Kevin Fitzgerald, Gregory Hinkle, Timothy Ryan Mooney
  • XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20180216114
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.
    Type: Application
    Filed: July 26, 2016
    Publication date: August 2, 2018
    Inventors: Kevin Fitzgerald, Gregory Hinkle, Timothy Ryan Mooney
  • SONET capable millimeter wave communication system
    Publication number: 20020176139
    Abstract: A point-to-point, wireless, millimeter wave trunk line communications link at high data rates in excess of 1 Gbps and at ranges of several miles during normal weather conditions to connect a local communication network through a SONET aggregation unit to a high speed fiber-optics network. In a preferred embodiment a trunk line communication link operates within the 92 to 95 GHz portion of the millimeter spectrum. A first transceiver transmits at a first bandwidth and receives at a second bandwidth both within the above spectral range. A second transceiver transmits at the second bandwidth and receives at the first bandwidth. The transceivers are equipped with antennas providing beam divergence small enough to ensure efficient spatial and directional partitioning of the data channels so that an almost unlimited number of transceivers will be able to simultaneously use the same spectrum.
    Type: Application
    Filed: December 18, 2001
    Publication date: November 28, 2002
    Inventors: Louis Slaughter, Randall Olsen, Chester Phillips, Paul Johnson, John Lovberg, Kenneth Y. Tang, George Houghton, Vladimir Kolinko, Ryan Mooney